Sigma Planning Corp trimmed its position in shares of Lam Research Corporation (NASDAQ:LRCX – Free Report) by 16.7% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 16,547 shares of the semiconductor company’s stock after selling 3,312 shares during the period. Sigma Planning Corp’s holdings in Lam Research were worth $5,411,000 as of its most recent SEC filing.
A number of other large investors also recently added to or reduced their stakes in the company. Cedar Mountain Advisors LLC lifted its position in shares of Lam Research by 242.9% during the first quarter. Cedar Mountain Advisors LLC now owns 120 shares of the semiconductor company’s stock worth $26,000 after purchasing an additional 85 shares in the last quarter. Paladin Partners LLC acquired a new position in shares of Lam Research in the second quarter valued at approximately $26,000. Quintet Private Bank Europe S.A. grew its holdings in shares of Lam Research by 100.0% in the third quarter. Quintet Private Bank Europe S.A. now owns 100 shares of the semiconductor company’s stock valued at $33,000 after purchasing an additional 50 shares in the last quarter. Dakota Community Bank & Trust NA purchased a new stake in Lam Research during the 3rd quarter worth approximately $33,000. Finally, Pin Oak Investment Advisors Inc. purchased a new stake in Lam Research during the 2nd quarter worth approximately $35,000. 84.61% of the stock is currently owned by institutional investors and hedge funds.
Lam Research Stock Up 3.2%
LRCX stock opened at $237.50 on Tuesday. The company’s 50 day moving average price is $302.39 and its 200 day moving average price is $282.90. The firm has a market capitalization of $296.68 billion, a price-to-earnings ratio of 35.39, a PEG ratio of 0.86 and a beta of 1.85. Lam Research Corporation has a fifty-two week low of $135.50 and a fifty-two week high of $438.50. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.86 and a current ratio of 2.48.
Lam Research (NASDAQ:LRCX – Get Free Report) last issued its quarterly earnings results on Wednesday, October 21st. The semiconductor company reported $2.20 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.18 by $0.02. Lam Research had a net margin of 32.34% and a return on equity of 72.15%. The company had revenue of $8.22 billion during the quarter, compared to the consensus estimate of $8.14 billion. During the same quarter in the previous year, the firm earned $1.26 earnings per share. The firm’s quarterly revenue was up 54.4% on a year-over-year basis. On average, equities research analysts anticipate that Lam Research Corporation will post 9.48 EPS for the current fiscal year.
Lam Research Increases Dividend
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, October 14th. Stockholders of record on Wednesday, September 23rd were given a dividend of $0.33 per share. This is an increase from Lam Research’s previous quarterly dividend of $0.26. The ex-dividend date of this dividend was Wednesday, September 23rd. This represents a $1.32 annualized dividend and a dividend yield of 0.6%. Lam Research’s dividend payout ratio is presently 19.67%.
Insiders Place Their Bets
In related news, insider Ava Harter sold 5,000 shares of the business’s stock in a transaction on Monday, August 31st. The shares were sold at an average price of $302.46, for a total transaction of $1,512,300.00. Following the completion of the transaction, the insider owned 42,462 shares in the company, valued at approximately $12,843,056.52. The trade was a 10.53% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Bethany Mayer sold 9,557 shares of the stock in a transaction on Wednesday, September 9th. The shares were sold at an average price of $314.74, for a total value of $3,007,970.18. Following the completion of the transaction, the director directly owned 20,995 shares in the company, valued at $6,607,966.30. This trade represents a 31.28% decrease in their position. The SEC filing for this sale provides additional information. Insiders own 0.31% of the company’s stock.
Wall Street Analyst Weigh In
LRCX has been the topic of a number of research reports. B. Riley Financial increased their target price on shares of Lam Research from $350.00 to $390.00 and gave the stock a “buy” rating in a report on Thursday, October 1st. Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a $375.00 price target on shares of Lam Research in a research note on Monday, October 19th. Evercore set a $315.00 price objective on Lam Research in a research report on Tuesday, October 20th. Wells Fargo & Company reiterated an “overweight” rating and issued a $350.00 target price (down from $450.00) on shares of Lam Research in a report on Thursday, July 30th. Finally, Susquehanna reiterated a “positive” rating and issued a $475.00 target price (up from $385.00) on shares of Lam Research in a report on Tuesday, June 30th. Twenty-six research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Lam Research has a consensus rating of “Moderate Buy” and a consensus price target of $360.23.
Read Our Latest Analysis on LRCX
Key Lam Research News
Here are the key news stories impacting Lam Research this week:
- Positive Sentiment: Lam Research stock gained despite a Citi price-target cut, suggesting investor confidence in the company’s fundamentals and AI-related demand outweighed the more cautious valuation view. Lam Research Stocks Gain 4.3% Despite Citi’s Target Cut
- Positive Sentiment: An analyst upgraded Lam Research, arguing that the stock’s decline has improved its risk-reward profile and that the underlying financial outlook has strengthened. Lam Research: Down 29% Since My Sell Call, But The Math Has Changed
- Positive Sentiment: An analyst raised the company’s fiscal 2027 EPS forecast, reinforcing expectations for continued earnings growth. FY2027 EPS Forecast for Lam Research Raised by Analyst
- Positive Sentiment: Long-term investment analyses remain bullish, citing strong cash flow, semiconductor demand and exposure to artificial-intelligence infrastructure as potential drivers of further upside. Lam Research vs. AMAT and KLAC Why Lam Research Is a Top Growth Stock
- Neutral Sentiment: A roundup of analyst actions involving LRCX indicates changing Wall Street views, but the specific recommendations and targets were mixed. Analyst Upgrades and Downgrades
- Neutral Sentiment: Reported short interest totaled zero shares, implying no measurable short-selling pressure; however, the unusual figure may reflect a reporting or data issue rather than a meaningful market signal.
- Negative Sentiment: Citi’s lower price target highlights valuation and near-term uncertainty, creating a potential headwind even though the broader market reaction was positive. Analysts Offer Insights on Lam Research
- Negative Sentiment: Recent weakness across AI and chip stocks, along with concerns about supply constraints and sharp sector corrections, shows that LRCX remains exposed to elevated semiconductor volatility. Chip Stocks to Buy After Their Worst Day Since June
About Lam Research
Lam Research Corporation (NASDAQ:LRCX) is a semiconductor equipment company that develops and manufactures systems used to fabricate integrated circuits. Its technologies support key stages of wafer processing, helping semiconductor manufacturers create the increasingly complex structures found in memory, logic and other types of chips.
The company’s product portfolio includes etch systems, which selectively remove materials from wafers; deposition systems, which apply thin films; and cleaning solutions used to remove contaminants and residue during manufacturing.
Recommended Stories
- Five stocks we like better than Lam Research
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
- 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
- Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants
Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX – Free Report).
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.
